The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer (Q35844068)

10 August 2017

1 reference

title

The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer (English)

1 reference

10 August 2017

1 reference

Kristin M Sanderson

1

1 reference

10 August 2017

John P Stein

series ordinal

2

1 reference

10 August 2017

Donald G Skinner

series ordinal

3

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

205-11; discussion 212-3

1 reference

Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Infiltrating Carcinoma of the Bladder: Relation of Depth of Penetration of the Bladder Wall to Incidence of Local Extension and Metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Pelvic lymph node dissection can be curative in patients with node positive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Regional gland dissection for carcinoma of the bladder; a technique for one-stage cystectomy, gland dissection, and bilateral uretero-enterostomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Surgery and adjunctive chemotherapy for invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Magnetic resonance imaging in the staging of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Insights into the mechanisms of lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

LYMPHATIC MAPPING AND DETECTION OF SENTINEL NODES IN PATIENTS WITH BLADDER CANCER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Superiority of ratio based lymph node staging for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.030

10.1016/J.UROLONC.2004.04.030

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference